Conversion from Positive to Negative EGFR Mutation due to Clonal Selection during Long-Term Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Case Report.

Ueda, Masatomo; Namba, Masashi; Tokumo, Kentaro; Senoo, Tadashi; Okamoto, Wataru; Yamauchi, Masami; Hattori, Noboru; Sugiyama, Kazuhiko

Ueda, Masatomo; Namba, Masashi; Tokumo, Kentaro; Senoo, Tadashi; Okamoto, Wataru; Yamauchi, Masami; Hattori, Noboru; Sugiyama, Kazuhiko.

Afiliación

Ueda M; Postgraduate Clinical Training Center, Hiroshima University Hospital, Hiroshima, Japan.
Namba M; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Tokumo K; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Senoo T; Department of Respiratory Medicine, National Hospital Organization, Kure Medical Center, Hiroshima, Japan.
Okamoto W; Cancer Treatment Center, Hiroshima University Hospital, Hiroshima, Japan.
Yamauchi M; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Hattori N; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Sugiyama K; Department of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.

Case Rep Oncol ; 14(3): 1447-1453, 2021.

Article en En | MEDLINE | ID: mdl-34899235

Palabras clave

Epidermal growth factor receptor mutation; Erlotinib; Gefitinib; Mechanisms of resistance; Non-small cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google